Erin McCreary, MD
Assistant Professor
Ob/Gyn, Reproductive Sciences
School of Medicine

Publications (77)

Top publication keywords:
Transplant RecipientsAcinetobacter baumanniiMycosesAzabicyclo CompoundsAntibodies, MonoclonalAlanineAnti-Bacterial AgentsAntineoplastic Agents, ImmunologicalGram-Negative BacteriaGram-Negative Bacterial InfectionsCommunicable DiseasesBacteremiaAntifungal AgentsAdenosine MonophosphateTriazoles

• Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.
  Pharmacotherapy 2026 Barreto EF, McCreary EK, Pai Mangalore R, Tang Girdwood S, Arriola R, Bens C, Bonomo RA, Edginton AN, Hong LT, Huttner A, Koch BCP, Maranchick N, Neely MN, Peloquin CR, Rao GG, Roberts JA, Röhr AC, …
• Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Ilges D, Shah A, Stevens RW, McCreary EK
• The changing epidemiology and long-term outcomes of patients with CRE infections.
  Antimicrobial stewardship & healthcare epidemiology : ASHE 2026 Shah S, Clarke LG, McCreary EK, Kline EG, Yucel E, Watanabe AH, Shields RK
• A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needs.
  Antimicrobial stewardship & healthcare epidemiology : ASHE 2026 Hirsch EB, Mott DA, Gilson AM, Aitken SL, Basalyga V, Bergman SJ, Buckel WR, DeSear KE, Farber M, Gaither CA, Gross AE, Hayney MS, McCreary EK, Nicol MR, Rose WE, Schommer JC, Wagner JL, Zembles TN, …
• You've Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026 Davis MR, Kufel JE, Kufel WD, McCreary EK, Oleksiuk LM, Ours R, Pham CU, Ross JK, Smith EA, Trisler MJ, Tverdek F

Show all (72 more) Hide

• Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE).
  Antimicrobial agents and chemotherapy 2025 Wangchinda W, Wu JY, Abbo LM, Ackley R, Bartley P, Gilboa M, Harrington J, Jaffa R, Klatt ME, Kline EG, Kubat RC, Lepak AJ, McCreary EK, Miller WR, Pearson JC, Shah S, Tran TT, Vega A, Vendetti M, …
• Non-β-Lactam Antibiotic Use, β-Lactam Allergy, and Surgical Site Infections.
  JAMA surgery 2025 Agarwal P, Kumar RP, Oleksiuk LM, Crall V, Petrov AA, McCreary EK, Holder-Murray J, Chang YF, Agarwal N, Hamilton DK, Friedlander RM
• New Pathways to Treat Staphylococcus aureus Bacteremia: Connecting the DOTS.
  JAMA 2025 McCreary EK, Malani PN
• Retrospective analysis of antimicrobial resistance among Escherichia coli causing community-acquired urinary tract infections in the United States from 2010 to 2022.
  Journal of global antimicrobial resistance 2025 Arends SJR, McCreary EK, Helgeson M, Morgan G, Patkar S, Mendes R
• Are bactericidal antibiotics necessary to effectively treat bloodstream infections?
  CMI communications 2025 Pulikeyil A, McDonald EG, McCreary EK, Tamma PD, Narayanan N
• Bacterial and fungal infections in persons who inject drugs.
  Clinical microbiology reviews 2025 Masters J, Goodman-Meza D, Russell D, Marks L, McCreary E, Jacka B, Seear K, Davis JS, Matthews G, Martinello M, Tong SYC, Dore GJ
• Population pharmacokinetics of meropenem-vaborbactam in acutely ill hospitalized patients with various degrees of renal dysfunction including continuous renal replacement therapy.
  Antimicrobial agents and chemotherapy 2025 Reed G, Valadez A, Smith BJ, McCreary EK, Kline EG, Neely MN, Squires KM, Shields RK, Rhodes NJ
• Optimizing Antibiotic Therapy in Musculoskeletal Infections.
  Infectious disease clinics of North America 2025 Cortés-Penfield NW, Justo JA, McCreary EK, Ryder JH
• Epidemiology, Treatment, and Outcomes of Gram-Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients.
  Clinical transplantation 2025 Doernberg SB, Heil EL, Fiawoo S, Lee JH, Cosgrove SE, Dobrzynski DM, Li Y, Shields RK, Spivak ES, Stohs EJ, Tamma PD, McCreary EK
• Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025 Shah S, Kline EG, Haidar G, Squires KM, Pogue JM, McCreary EK, Ludwig J, Clarke LG, Stellfox M, Van Tyne D, Shields RK
• Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
  The Lancet. Infectious diseases 2024 Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi EY, Gross AE, Hand J, Heil EL, Hornback KM, Kaye KS, Khuu…
• REVISITing treatment of metallo-β-lactamases.
  The Lancet. Infectious diseases 2024 Heil EL, McCreary EK
• Therapeutic Myths in Solid Organ Transplantation Infectious Diseases.
  Open forum infectious diseases 2024 Goodlet KJ, McCreary EK, Nailor MD, Barnes D, Brokhof MM, Bova S, Clemens E, Kelly B, Lichvar A, Pluckrose DM, Summers BB, Szempruch KR, Tchen S
• Impact of a pharmacy-driven MRSA nares screening protocol on vancomycin discontinuation in a tele-antimicrobial stewardship model.
  Antimicrobial stewardship & healthcare epidemiology : ASHE 2024 Trzebucki AM, Davis MR, McCreary EK, Cuccaro S, Bariola JR, Khadem T
• Our "Side Hustle".
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 McCreary EK
• Things We Do for No Reason - Ordering Streptococcus Pneumoniae Urinary Antigen in Patients With Community-Acquired Pneumonia.
  Open forum infectious diseases 2024 Davis MR, McCreary EK, Trzebucki AM
• Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections.
  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2024 Osowicki J, Hamilton F, Lee TC, Marks M, McCreary EK, McDonald EG, Ryder JH, Tong SYC
• Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 Soto CL, Hsu AJ, Lee JH, Dzintars K, Choudhury R, Jenkins TC, McCreary EK, Quartuccio KS, Stohs EJ, Zimmerman M, Tamma PD
• Transition to Oral Antibiotic Therapy for Hospitalized Adults With Gram-Negative Bloodstream Infections.
  JAMA network open 2024 Engers DW, Tamma PD, Fiawoo S, Fong K, Jariwala R, Jenkins TC, Kendall RE, Lee JH, McCreary EK, Patel PK, Shihadeh KC, Slish J, Van Schooneveld TC, Malani AN
• Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock.
  Open forum infectious diseases 2023 O'Donnell M, Shields RK, Marini RV, Groetzinger LM, Potoski BA, Falcione BA, Shah S, McCreary EK, Clarke L, Brant E, McVerry BJ, Liegey S, Pasculle AW, Clancy CJ, Nguyen MH
• Acute Kidney Injury With Empirical Antibiotics for Sepsis.
  JAMA 2023 Tong SYC, Venkatesh B, McCreary EK
• Antibiotic Myths for the Infectious Diseases Clinician.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 McCreary EK, Johnson MD, Jones TM, Spires SS, Davis AE, Dyer AP, Ashley ED, Gallagher JC
• Weighted Lottery to Equitably Allocate Scarce Supply of COVID-19 Monoclonal Antibody.
  JAMA health forum 2023 McCreary EK, Essien UR, Chang CH, Butler RA, Pathak P, Sönmez T, Ünver MU, Steiner A, Chrisman M, Angus DC, White DB
• Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
  Pharmacotherapy 2023 McCreary EK, Davis MR, Narayanan N, Andes DR, Cattaneo D, Christian R, Lewis RE, Watt KM, Wiederhold NP, Johnson MD
• Rapid Emergence of Potentially Transmissible Severe Acute Respiratory Syndrome Coronavirus 2 With Resistance to Combination Monoclonal Antibody Therapy.
  Open forum infectious diseases 2023 Jacobs JL, Haidar G, Naqvi A, McCormick KD, Sobolewski M, Treat BR, Heaps AL, Simpson J, Kramer KH, McCreary E, Bariola JR, Klamar-Blain C, Macatangay BJC, Dimitrov D, Li W, Marino CC, Raptis A, Sethi…
• Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection.
  Open forum infectious diseases 2023 Dorazio J, Chiappelli AL, Shields RK, Tsai YV, Skinker P, Nabozny MJ, Bauza G, Forsythe R, Rosengart MR, Gunn SR, Marini R, Clarke L, Falcione B, Ludwig J, McCreary EK
• Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
  Annals of internal medicine 2023 Kip KE, McCreary EK, Collins K, Minnier TE, Snyder GM, Garrard W, McKibben JC, Yealy DM, Seymour CW, Huang DT, Bariola JR, Schmidhofer M, Wadas RJ, Angus DC, Kip PL, Marroquin OC
• Monoclonal Antibodies for the Treatment of COVID-19-Every Day You Fight Like You're Running Out of Time.
  JAMA network open 2023 McCreary EK, Escobar ZK, Justo JA
• Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023 Albin OR, Kaye KS, McCreary EK, Pogue JM
• Tixagevimab Plus Cilgavimab Does Not Affect the Interpretation of Electrophoretic and Free Light Chain Assays.
  American journal of clinical pathology 2023 Baloda V, McCreary EK, Goscicki BK, Shurin MR, Wheeler SE
• What is the place in therapy for nirmatrelvir/ritonavir?
  BMJ evidence-based medicine 2022 Lee TC, Pogue JM, McCreary EK, Morris AM
• Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy : A Cohort Study.
  Annals of internal medicine 2022 McCreary EK, Lemon L, Megli C, Oakes A, Seymour CW, UPMC Magee Monoclonal Antibody Treatment Group
• Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
  Open forum infectious diseases 2022 McCreary EK, Kip KE, Collins K, Minnier TE, Snyder GM, Steiner A, Meyers R, Borneman T, Adam M, Thurau L, Yealy DM, Huang DT, Bariola JR, Schmidhofer M, Wadas RJ, Angus DC, Kip PL, Marroquin OC
• A Multicenter Weighted Lottery to Equitably Allocate Scarce COVID-19 Therapeutics.
  American journal of respiratory and critical care medicine 2022 White DB, McCreary EK, Chang CH, Schmidhofer M, Bariola JR, Jonassaint NN, Persad G, Truog RD, Pathak P, Sonmez T, Unver MU
• Monoclonals for patients hospitalised with COVID-19.
  The Lancet. Respiratory medicine 2022 Pogue JM, McCreary EK
• Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
  JAMA network open 2022 Huang DT, McCreary EK, Bariola JR, Minnier TE, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Kip KE, Collins K, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Weissman A, Garrard W,…
• The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
  Contemporary clinical trials 2022 McCreary EK, Bariola JR, Minnier TE, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Kip KE, Collins K, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Weissman A, Garrard W, Peck-…
• Impact of Clinical Decision Support System Implementation at a Community Hospital With an Existing Tele-Antimicrobial Stewardship Program.
  Open forum infectious diseases 2022 Khadem TM, Ergen HJ, Salata HJ, Andrzejewski C, McCreary EK, Abdel Massih RC, Bariola JR
• Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
  JAMA network open 2022 McCreary EK, Bariola JR, Wadas RJ, Shovel JA, Wisniewski MK, Adam M, Albin D, Minnier T, Schmidhofer M, Meyers R, Marroquin OC, Collins K, Garrard W, Berry LR, Berry S, Crawford AM, McGlothlin A, …
• A learning health system approach to the COVID-19 pandemic: System-wide changes in clinical practice and 30-day mortality among hospitalized patients.
  Learning health systems 2022 McCreary EK, Kip KE, Bariola JR, Schmidhofer M, Minnier T, Mayak K, Albin D, Daley J, Linstrum K, Hernandez E, Sackrowitz R, Hughes K, Horvat C, Snyder GM, McVerry BJ, Yealy DM, Huang DT, Angus DC, …
• Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
  Contemporary clinical trials 2021 McCreary EK, Bariola JR, Minnier T, Wadas RJ, Shovel JA, Albin D, Marroquin OC, Schmidhofer M, Wisniewski MK, Nace DA, Sullivan C, Axe M, Meyers R, Khadem T, Garrard W, Collins K, Wells A, Bart RD, …
• Long-Acting Lipoglycopeptides Can Interfere With Vancomycin Therapeutic Drug Monitoring.
  Journal of clinical pharmacology 2021 Smelter DF, Trisler MJ, McCreary EK, Baker M, Copeland K, Dilworth TJ, Rose WE
• Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment.
  Journal of the American College of Emergency Physicians open 2021 Woltemate TJ, Wadas RJ, McCreary EK, Bariola R, Minnier T, Marroquin OC, Schmidhofer M, Albin D, Angus DC, Yealy DM
• Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring.
  Medical mycology 2021 Davis MR, Chang S, Gaynor P, McCreary EK, Allyn P
• Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Samanta P, Clancy CJ, Marini RV, Rivosecchi RM, McCreary EK, Shields RK, Falcione BA, Viehman A, Sacha L, Kwak EJ, Silveira FP, Sanchez PG, Morrell M, Clarke L, Nguyen MH
• New Perspectives on Antimicrobial Agents: Cefiderocol.
  Antimicrobial agents and chemotherapy 2021 McCreary EK, Heil EL, Tamma PD
• The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
  Trials 2021 Huang DT, McCreary EK, Bariola JR, Wadas RJ, Kip KE, Marroquin OC, Koscumb S, Collins K, Shovel JA, Schmidhofer M, Wisniewski MK, Sullivan C, Yealy DM, Axe M, Nace DA, Haidar G, Khadem T, Linstrum K, …
• Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
  Open forum infectious diseases 2021 Bariola JR, McCreary EK, Wadas RJ, Kip KE, Marroquin OC, Minnier T, Koscumb S, Collins K, Schmidhofer M, Shovel JA, Wisniewski MK, Sullivan C, Yealy DM, Nace DA, Huang DT, Haidar G, Khadem T, Linstrum…
• Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic.
  Open forum infectious diseases 2021 Bariola JR, McCreary EK, Khadem T, Snyder GM, Wadas RJ, Nace DA, White DB, Yealy DM, Schmidhofer M
• Comprehensive Care Improvement for Oncologic Fever and Neutropenia from a Pediatric Emergency Department.
  Pediatric quality & safety 2021 Kuehnel NA, McCreary E, Henderson SL, Vanderloo JP, Hoover-Regan ML, Sharp B, Ross J
• Covid-19 controversies: the tocilizumab chapter.
  BMJ (Clinical research ed.) 2021 McCreary EK, Meyer NJ
• Remdesivir: a pendulum in a pandemic.
  BMJ (Clinical research ed.) 2020 Schwartz IS, Heil EL, McCreary EK
• Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis.
  Open forum infectious diseases 2020 McCreary EK, Byers KE, Fernandes C, Kline EG, Nicolau DP, Shields RK
• Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic.
  JAMA 2020 Seymour CW, McCreary EK, Stegenga J
• Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tube.
  The Journal of antimicrobial chemotherapy 2020 McCreary EK, Nguyen MH, Davis MR, Borlagdan J, Shields RK, Anderson AD, Rivosecchi RM, Marini RV, Sacha LM, Silveira FP, Andes DR, Lepak AJ
• Efficacy of Remdesivir in COVID-19.
  JAMA 2020 McCreary EK, Angus DC
• Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 Shields RK, McCreary EK, Marini RV, Kline EG, Jones CE, Hao B, Chen L, Kreiswirth BN, Doi Y, Clancy CJ, Nguyen MH
• That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19.
  Infectious diseases and therapy 2020 Davis MR, McCreary EK, Pogue JM
• Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience.
  Drugs - real world outcomes 2020 Brownell LE, Adamsick ML, McCreary EK, Vanderloo JP, Ernst EJ, Jackson ER, Schulz LT
• Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.
  Open forum infectious diseases 2020 McCreary EK, Pogue JM
• Healthcare practitioners' views of social media as an educational resource.
  PloS one 2020 Pizzuti AG, Patel KH, McCreary EK, Heil E, Bland CM, Chinaeke E, Love BL, Bookstaver PB
• Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments.
  Open forum infectious diseases 2019 McCreary EK, Kullar R, Geriak M, Zasowski EJ, Rizvi K, Schulz LT, Ouellette K, Vasina L, Haddad F, Rybak MJ, Zervos MJ, Sakoulas G, Rose WE
• Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.
  Antimicrobial agents and chemotherapy 2019 McCreary EK, Bayless M, Van AP, Lepak AJ, Wiebe DA, Schulz LT, Andes DR
• Finding the niche: An interprofessional approach to defining oritavancin use criteria in the emergency department.
  The American journal of emergency medicine 2019 Baxa J, McCreary E, Schulz L, Pulia M
• Interplay between Rapid Diagnostic Tests and Antimicrobial Stewardship Programs among Patients with Bloodstream and Other Severe Infections.
  The journal of applied laboratory medicine 2018 Beganovic M, McCreary EK, Mahoney MV, Dionne B, Green DA, Timbrook TT
• Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study.
  Open forum infectious diseases 2018 Gallagher JC, Satlin MJ, Elabor A, Saraiya N, McCreary EK, Molnar E, El-Beyrouty C, Jones BM, Dixit D, Heil EL, Claeys KC, Hiles J, Vyas NM, Bland CM, Suh J, Biason K, McCoy D, King MA, Richards L, …
• In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistance.
  Diagnostic microbiology and infectious disease 2018 Kinn PM, Chen DJ, Gihring TM, Schulz LT, Fox BC, McCreary EK, Lepak AJ
• High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients.
  The Annals of pharmacotherapy 2017 Jorgenson MR, Descourouez JL, Leverson GE, McCreary EK, Lucey MR, Smith JA, Redfield RR
• Top 10 Myths Regarding the Diagnosis and Treatment of Cellulitis.
  The Journal of emergency medicine 2017 McCreary EK, Heim ME, Schulz LT, Hoffman R, Pothof J, Fox B
• Adult vaccines for individuals with human immunodeficiency virus infection.
  Journal of the American Pharmacists Association : JAPhA 2015 McCreary EK, Hayney MS
• Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 Wargo KA, McCreary EK, English TM
• Adoption, acceptability, and accuracy of an online clinical trial matching website for breast cancer.
  Journal of medical Internet research 2012 Cohen E, Belkora J, Tyler J, Schreiner J, Deering MJ, Grama L, Duggan B, Illi J, Pederson J, Anand A, Teng A, McCreary E, Moore D, Tripathy D, Hogarth M, Lieberman M, Park J, Esserman L